← All trials
NCT02797119
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2016
- Primary completion
- Feb 1, 2018
- Completion date
- Feb 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 390
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of LilleLead sponsor
- French Health Products Safety AgencyCollaborator
- Government of FranceCollaborator
- University of LilleOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.